(Q51835555)

13 April 2018

title

Cardiomyocyte function associated with hyperactivity and/or hypertension in genetic models of LV hypertrophy. (English)

1 reference

13 April 2018

author name string

Bradley M Palmer

1

1 reference

13 April 2018

Zengyi Chen

2

1 reference

13 April 2018

Richard R Lachapelle

3

1 reference

13 April 2018

Edith D Hendley

4

1 reference

13 April 2018

Martin M LeWinter

5

1 reference

13 April 2018

publication date

21 October 2005

1 reference

13 April 2018

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

13 April 2018

volume

290

1 reference

13 April 2018

issue

1

1 reference

13 April 2018

page(s)

H463-73

1 reference

13 April 2018

Differential development of vascular and cardiac hypertrophy in genetic hypertension. Relation to sympathetic function.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00310.2005

Studies of prevention, treatment and mechanisms of heart failure in the aging spontaneously hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00310.2005

Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00310.2005

Myocardial hypertrophy and ventricular performance in the absence of hypertension in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00310.2005

Development of left ventricular hypertrophy in young spontaneously hypertensive rats after peripheral sympathectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00310.2005

In search of cardiovascular candidate genes: interactions between phenotypes and genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00310.2005

Functional alterations of the Nppa promoter are linked to cardiac ventricular hypertrophy in WKY/WKHA rat crosses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00310.2005

Enhanced Vascular Neuropeptide Y– Immunoreactive Innervation in Two Hypertensive Rat Strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00310.2005

Inbreeding of Wistar-Kyoto rat strain with hyperactivity but without hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00310.2005

WKHA rats with genetic hyperactivity and hyperreactivity to stress: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00310.2005

Stress, behavior and experimental hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00310.2005

Type A behavior is associated with an increased risk of left ventricular hypertrophy in male patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00310.2005

Mapping of quantitative trait loci for blood pressure and cardiac mass in the rat by genome scanning of recombinant inbred strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00310.2005

Low power, type II errors, and other statistical problems in recent cardiovascular research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00310.2005

10.1152/AJPHEART.00310.2005

21 January 2018

Identifiers

DOI

1 reference

13 April 2018

1 reference

13 April 2018